Unique ID issued by UMIN | UMIN000020779 |
---|---|
Receipt number | R000023981 |
Scientific Title | A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity. |
Date of disclosure of the study information | 2016/02/01 |
Last modified on | 2018/08/09 10:11:14 |
A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity.
A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity.
A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity.
A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity.
Japan |
Open distal gastrectomy
Gastrointestinal surgery |
Malignancy
NO
To study whether preoperative administration of amino acids, cystine and theanine, accelerate recovery from postoperative reduction of activity amount.
Efficacy
Exploratory
Pragmatic
Phase II
Changes in amount of activity from 2 days before to 1 week after surgery measured using wristwatch-type motion logger.
Hematological and blood biochemistry indices before and 1, 3, 7, 14days after surgery.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Prevention
Food |
Ingestion of supplement containing 700mg of cystine and 280mg of theanine once daily for 10 days from 2days before until 7days after surgery.
No ingestion of supplement instead of the cystine and theanine.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Received a written informed consent by patient's self-determination.
2.Scheduled to receive open distal gastrectomy.
3.From 20 to less than 80 years old.
4.No severe complication before surgery.
1.Phenyl ketonuria.
2.Active infection.
3.Poorly controlled hypertension.
4.Poorly controlled diabetes.
5.Clinically important cardiac disease.
6.Severe pulmonary disease(e.g. interstitial pneumonia, fibrosis, severe emphysema).
7.History of clinically important psychopathic disorder or central nervous system damage.
8.Continuous systemic administration(iv or po) of steroid.
9.Pregnancy, breast-feeding, possible pregnancy, and willing to be pregnant.
10.Particpation for other studies.
11.Impossible of oral ingestion.
12.Judged ineligible by the principal investigator of sub-investigator.
30
1st name | |
Middle name | |
Last name | Takashi Tsuchiya |
Sendai City Medical Center Sendai Open Hospital
Director, GI Surgery
5-22-1 Tsurugaya , Miyagino-ku, Sendai City, Miyagi
022-252-1111
tsuchiya@openhp.or.jp
1st name | |
Middle name | |
Last name | Takashi Tsuchiya |
Sendai City Medical Center Sendai Open Hospital
Director, GI Surgery
5-22-1 Tsurugaya , Miyagino-ku, Sendai City, Miyagi
022-252-1111
tsuchiya@openhp.or.jp
Sendai City Medical Center Sendai Open Hospital
Ajinomoto Co., Inc.
Profit organization
Japan
NO
2016 | Year | 02 | Month | 01 | Day |
Unpublished
Terminated
2016 | Year | 01 | Month | 10 | Day |
2016 | Year | 02 | Month | 01 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 04 | Month | 30 | Day |
2018 | Year | 05 | Month | 30 | Day |
2016 | Year | 01 | Month | 28 | Day |
2018 | Year | 08 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023981
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |